S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
S&P 500   3,465.39 (+0.34%)
DOW   28,335.57 (-0.10%)
QQQ   284.74 (+0.20%)
AAPL   115.04 (-0.61%)
MSFT   216.23 (+0.62%)
FB   284.79 (+2.40%)
GOOGL   1,632.98 (+1.64%)
AMZN   3,204.40 (+0.88%)
TSLA   420.63 (-1.21%)
NVDA   543.61 (+1.72%)
BABA   309.92 (+1.19%)
CGC   19.73 (-2.81%)
GE   7.63 (-1.17%)
MU   52.85 (-2.81%)
AMD   81.96 (+3.20%)
T   27.82 (-1.63%)
F   8.16 (-0.61%)
ACB   4.68 (-3.51%)
GILD   60.79 (+0.20%)
NFLX   488.28 (+0.63%)
BA   167.36 (-1.01%)
NIO   27.16 (-0.80%)
DIS   128.35 (+0.62%)
Log in
NYSE:CTST

CannTrust Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
C$0.64
0.00 (0.00 %)
(As of 04/14/2020)
Add
Compare
Today's Range
C$0.64
Now: C$0.64▼
C$0.64
50-Day Range
C$0.64
MA: C$0.64▼
C$0.64
52-Week Range
C$0.38
Now: C$0.64▼
C$8.17
VolumeN/A
Average VolumeN/A
Market CapitalizationC$90.27 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
CannTrust Holdings Inc. produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.
Read More
CannTrust logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.61 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:CTST
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.canntrust.ca
Phone64-7872-2300
Employees576

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesC$35.22 million
Price / Sales2.56
Cash FlowN/A
Price / Cash FlowN/A
Book ValueC$1.27 per share
Price / Book0.50

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares141,490,000
Market CapC$90.27 million
Next Earnings DateN/A
OptionableOptionable

Receive CTST News and Ratings via Email

Sign-up to receive the latest news and ratings for CTST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CannTrust (NYSE:CTST) Frequently Asked Questions

Who are some of CannTrust's key competitors?

Some companies that are related to CannTrust include AC Immune (ACIU), ANI Pharmaceuticals (ANIP), Concert Pharmaceuticals (CNCE), Orphazyme A/S (ORPH), iBio (IBIO), BioDelivery Sciences International (BDSI), Aeglea Bio Therapeutics (AGLE), NextCure (NXTC), Magenta Therapeutics (MGTA), Spero Therapeutics (SPRO), Bicycle Therapeutics (BCYC), Pandion Therapeutics (PAND), Catalyst Pharmaceuticals (CPRX), TFF Pharmaceuticals (TFFP) and VYNE Therapeutics (VYNE).
View all competitors.

What other stocks do shareholders of CannTrust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACB), OrganiGram (OGI), HEXO (HEXO), Nokia (NOK) and Aphria Inc. (APHA.TO) (APHA).

Who are CannTrust's key executives?

CannTrust's management team includes the following people:
  • Mr. Eric Paul, Co-Founder & Chairman (Age 78)
  • Mr. Brad Rogers, Pres (Age 49)
  • Mr. Ian Abramowitz, Sr. VP of Global Investments & Partnerships (Age 64)
  • Mr. Peter Ralph Aceto, Chief Exec. Officer
  • Mr. Greg Guyatt, Chief Financial Officer

What is CannTrust's stock symbol?

CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST."

What is CannTrust's stock price today?

One share of CTST stock can currently be purchased for approximately C$0.64.

How big of a company is CannTrust?

CannTrust has a market capitalization of C$90.27 million and generates C$35.22 million in revenue each year. CannTrust employs 576 workers across the globe.

What is CannTrust's official website?

The official website for CannTrust is www.canntrust.ca.

How can I contact CannTrust?

CannTrust's mailing address is 3280 LANGSTAFF ROAD UNIT 1, VAUGHAN A6, L4K 4Z8. The company can be reached via phone at 64-7872-2300 or via email at [email protected]

This page was last updated on 10/23/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.